PTEN, tau-AP-3, thymidylate synthase immunohistochemistry scoring expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignancy potential and uterine leiomyosarcomas

Huang, L.C.; Ye, J.C.; Hsieh, C.H.; Chen, L.M.; Lin, T.Y.; Hung, Y.C.; Chang, W.C.; Huang, L.C; Ye, J.C; Hsieh, C.H; Chen, L.M; Lin, T.Y; Hung, Y.C; Chang, W.C

Home

>

Node

>

Subnode

PTEN, tau-AP-3, thymidylate synthase immunohistochemistry scoring expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignancy potential and uterine leiomyosarcomas

Huang, L.C.; Ye, J.C.; Hsieh, C.H.; Chen, L.M.; Lin, T.Y.; Hung, Y.C.; Chang, W.C.

European Journal of Gynaecological Oncology 32(5): 496-499

2011

ISSN/ISBN: 0392-2936

PMID: 22053660

Document Number: 651349

Uterine smooth muscle tumors are frequently classified as benign and malignant. However, an assortment of mitotic counts and nuclear atypia can be indecisive between uncertain malignant potential, and malignant uterine smooth muscle tumors. We applied three immunohistochemical parameters to distinguish between cases of benign, malignant, and those with uncertain malignant histology.